Article Text
Editorial
B type natriuretic peptide testing: where are we now?
Abstract
It is possible that plasma BNP measurement might be to heart failure what glycated haemoglobin measurement is to diabetes mellitus. Indeed, within 12–24 months, BNP testing might become a routine addition to the monitoring of patients with heart failure. In the meantime its main role is in helping to rule out heart failure in patients with new symptoms
- ACS, acute coronary syndrome
- BATTLE, SCARRED
- BNP, assisted treatment to lessen serial cardiovascular readmissions and dealth
- BNP, B type natriuretic peptide
- MONICA, monitoring trends and determinants in cardiovascular disease
- NICE, National Institute for Clinical Excellence
- NTproBNP, N terminal proBNP
- ROC, receiver operating characteristic
- STARS, suivi du traitement dans I’insuffisance cardiaque systolique
- B type natriuretic peptide
- BNP
- heart failure
Statistics from Altmetric.com
- ACS, acute coronary syndrome
- BATTLE, SCARRED
- BNP, assisted treatment to lessen serial cardiovascular readmissions and dealth
- BNP, B type natriuretic peptide
- MONICA, monitoring trends and determinants in cardiovascular disease
- NICE, National Institute for Clinical Excellence
- NTproBNP, N terminal proBNP
- ROC, receiver operating characteristic
- STARS, suivi du traitement dans I’insuffisance cardiaque systolique
Linked Articles
- Miscellanea
- Miscellanea
- Miscellanea